Amyloidogenesis is significant in both protein function and pathology. Amyloid formation of folded, globular proteins is commonly initiated by partial unfolding. However, how this unfolding event is triggered for proteins that are otherwise stable in their native environments is not well understood. The accumulation of the immunoglobulin protein β 2 -microglobulin (β 2 m) into amyloid plaques in the joints of long-term hemodialysis patients is the hallmark of Dialysis Related Amyloidosis (DRA). While β 2 m does not form amyloid unassisted near neutral pH in vitro, the localization of β 2 m deposits to joint spaces suggests a role for the local extracellular matrix (ECM) proteins, specifically collagens, in promoting amyloid formation. Indeed, collagen and other ECM components have been observed to facilitate β 2 m amyloid formation, but the large size and anisotropy of the complex, combined with the low affinity of these interactions, has limited atomic-level elucidation of the amyloid-promoting mechanism by these molecules. Using solution NMR approaches that uniquely probe weak interactions and large complexes, we are able to derive binding interfaces for collagen I on β 2 m and detect collagen I-induced µsms timescale dynamics in the β 2 m backbone. By combining solution NMR relaxation methods and 15 N-dark state exchange saturation transfer experiments, we propose a model in which weak, multimodal collagen I-β 2 m interactions promote exchange with a minor population of an amyloid-competent species to induce fibrillogenesis. The results portray the intimate role of the environment in switching an innocuous protein into an amyloid-competent state, rationalizing the localization of amyloid deposits in DRA.
INTRODUCTION
Several proteins self-associate into amyloid fibrils, which in some cases have functional roles [1] [2] [3] , but for others are associated with debilitating human diseases [4] [5] [6] including Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, type II diabetes, cataracts, and Dialysis Related Amyloidosis (DRA). The protein precursors of amyloid diseases have unrelated primary sequences and structures 7 , spanning natively unfolded (intrinsically disordered) states, such as α-synuclein, amyloid-β peptide, and tau [8] [9] [10] , to stable, globular proteins, such as β 2microglobulin (β 2 m), transthyretin, and immunoglobulin light chains [11] [12] [13] . Initiation of amyloid formation of the latter class of proteins requires unfolding or partial unfolding of monomeric precursors, which can transiently assume amyloid-competent state(s). This kinetic barrier may be lower for intrinsically disordered proteins. However, what triggers the initial unfolding and subsequent amyloidogenesis of natively folded globular proteins remains poorly understood.
Accumulation of β 2 m amyloid plaques in the joints of long-term hemodialysis patients leads to DRA and arthritic symptoms [14] [15] [16] [17] . In healthy individuals, β 2 m dissociates from the major histocompatibility complex-I (MHC-I), is released into the plasma, and is carried to the kidneys for degradation [18] [19] . However, when hemodialysis or peritoneal dialysis are required due to kidney failure, β 2 m is not efficiently removed from the plasma, leading to increased concentrations by up to 60-fold 16, [20] [21] . Remarkably, despite being transported throughout the body, β 2 m accumulates into amyloid plaques specifically in skeletal tissues of dialysis patients 16, [21] [22] [23] [24] . The mechanism(s) by which β 2 m fibrillizes in vivo is not well understood, since in isolation the wild-type protein (the major culprit of DRA) resists amyloid formation in physiological conditions, even at high (100 µM) concentrations [25] [26] . It has been proposed that β 2 m amyloid localized in the joints could result, at least in part, from interactions with the major components of the extracellular matrix (ECM) in bone and cartilage: collagens I and II 20-23 and glycosaminoglycans (GAGs) [27] [28] [29] . The binding affinities of β 2 m to these collagens have been shown to be in the µM-mM range 30 with preference for collagen I 27 . Although the interaction is weak, it is nonetheless pathologically significant, as images of ex vivo DRA plaques reveal β 2 m amyloid covering the surface of collagen I fibrils 21 . Indeed, recent kinetics studies have revealed that ECM components, such as collagens 21, [28] [29] and GAGs [28] [29] [31] [32] , as well as pre-formed fibril seeds and other co-factors 25-26, 28, 31-49 , induce and modulate β 2 m amyloid formation. However, atomic details of how these components interact with, and induce, the amyloid formation of β 2 m have remained an open question.
The weak nature of the interaction and large, anisotropic shape of the β 2 m-collagen I complex create a challenge for deriving atomic-level information on how collagen I-β 2 m interactions initiate β 2 m amyloidogenesis. The immunoglobulin fold of monomeric β 2 m has dimensions of ~ 4 nm x 2 nm x 2 nm, whereas the simplest triple helical unit of collagen I has strikingly larger dimensions of 300 nm x 1.5 nm x 1.5 nm.
Collagen I triple helices assemble into even larger, structured fibrils that have diameters ranging from 10-500 nm and lengths on the µmscale. Collagen I therefore presents as a large surface with numerous reactive groups for β 2 m interactions. These challenges are not insurmountable, however, as powerful solution nuclear magnetic resonance (NMR) spectroscopy methods can indirectly probe large, lowly populated complexes in site-specific detail that are invisible by other biophysical techniques.
In this study, by utilizing NMR spectroscopy experiments designed to probe large complexes, we are able to pinpoint the binding interface of wild-type β 2 m for collagen I at physiological pH and have shown it to involve both β-sheets of the native protein, suggestive of different binding modes for the same molecular complex. Residues identified at the binding interface include both hydrophobic and hydrophilic sidechains. Through 15 N relaxation experiments, we have also found that collagen I increases the number of residues in β 2 m involved in conformational exchange on the µs-ms timescale. These regions include residues 6-11 (β-strand A), 36-39 (β-strand C), 51 (β-strand D), and 91-94 (β-strand G) in the edge β-strands and loop residues 15-20 (loop AB), 35 (loop BC), 52-53 (loop DE), 63 (loop DE), and 78 (loop EF), the dynamics and conformations of which are known to be important for β 2 m amyloid formation 31, 38, [50] [51] . We propose that the weak interactions of collagen I with the β 2 m β-sheets promote exchange of the native protein with a minor population of amyloid-competent species that induce fibrillogenesis. This study illuminates how a protein component, collagen I, local to the environment in which β 2 m plaques are found, can interact with a stable, globular protein to initiate debilitating amyloid formation.
RESULTS

Collagen I induces β 2 m amyloid formation in a concentration-dependent manner.
Since the direct interaction of β 2 m with collagen in the joint space has been proposed to induce β 2 m amyloid formation 21, 27 , we probed the β 2 m-collagen I interaction under physiological pH conditions (pH 7.4) using a solid-phase enzyme-linked immunosorbent assays (ELISA) ( Figure 1A ). Importantly, the results suggest a dose-dependent interaction of the two proteins, consistent with previously published results 27 , under the conditions employed here. The adhesion of β 2 m to casein was monitored as a negative control, for which no significant binding was observed ( Figure 1A) .
Having verified the β 2 m-collagen I interaction under physiological pH conditions, we next monitored amyloid growth of β 2 m in the presence or absence of collagen I by thioflavin T (ThT) fluorescence ( Figure 1B ). In the presence of 3.4 mg/ml collagen I (1:0.1 molar ratio β 2 m:collagen I), β 2 m amyloid is formed within 12-21 days ( Figure 1B , blue), as evident by enhanced ThT fluorescence. This is not observed in the absence of collagen I in the same conditions, and collagen I alone does not show ThT fluorescence enhancement ( Figure 1B) . Notably, at lower concentrations of collagen I, lower β 2 m concentrations, or shorter timescales fibrils are not observed 29, 31 . Atomic force microscopy (AFM) images also show that β 2 m interacts with collagen I fibrils, with β 2 m coating the collagen I fibril surface before detectable fibril formation by ThT fluorescence, obscuring the characteristic collagen I fibril D-banding that is clearly observed in the absence of β 2 m ( Figure  1C ,D), consistent with previous results 21 . β 2 m alone ( Figure 1E ) does not aggregate in the conditions employed, with no fibrils or high molecular weight assemblies observed by AFM. These data confirm that adhesion of collagen I to β 2 m induces β 2 m amyloid formation under physiological conditions in vitro, while the protein is not able to form amyloid in the absence of collagen I. In order to understand mechanistic details by which collagen I interacts with β 2 m to initiate amyloid formation, we used solution NMR methods, which provide an excellent toolbox of approaches able to characterize residue-specific features of weak protein-protein interactions on multiple timescales [52] [53] [54] [55] . A titration of collagen I into a β 2 m monomer solution showed no significant chemical shift perturbations in 1 H-15 N heteronuclear single quantum correlation (HSQC) spectra ( Figure S1 ). However, a residue-specific attrition of the peak intensities observed with increasing collagen I concentrations (Figure 2A ), suggests chemical exchange between the bound and free states of β 2 m consistent with the low affinity of the interaction in these conditions (K d ≈ 410 µM 30 ). To minimize collagen I aggregation during the NMR experiments and to capture the most specific interactions, we proceeded with low collagen I concentrations (0.6-1.2 mg/ml) that displayed consistent residue-specific perturbations and kept samples at 10°C, allowing NMR spectra to be acquired for over one week without visible alterations in spectral quality. Addition of 1.2 mg/ml collagen I to 300 µM β 2 m resulted in a reduction in resonance intensity of all peaks, consistent with transient formation of a high molecular weight complex (Figure 2A ). However, the greatest reduction in peak intensities occurred for residues in the eight β-strands of the wild-type protein (Figure 2A ). These peak intensity losses are in part due to increased 15 Ntransverse relaxation rates (R 2 ), which are sensitive to changes in internal motions on the ps-ns timescale and conformational exchange on the µs-ms timescale. Indeed, at these concentrations, we observe an overall increase in 15 N-R 2 , but importantly, the increase is not uniform across all residues, but is residue specific, involving predominantly residues 2-3 (N-terminus), 7-11 (β-strand A), 16-19 (loop AB), 23-26 (β-strand B), 35-39 (β-strand C), 50-52 (β-strand D), 64, 66-69 (β-strand E), 79-82 (β-strand F), 85, 87 (loop FG), and 91-94 (C-terminal βstrand G) ( Figure 2B -C). The increased 15 N-R 2 at these specific sites could have multiple origins, arising due to reduced backbone mobility upon direct interaction with collagen I and/or to line broadening due to exchange between species with different chemical shifts, especially since the observed 15 N-ΔR 2 is dependent on magnetic field (700 MHz vs. 900 MHz, Fig. S2 ). In order to disentangle these contributions to the increase in 15 N-R 2 , we proceeded with two sets of NMR experiments: 15 N-dark state exchange saturation transfer (DEST) experiments, which can identify residues interacting with the large complex, and in-phase Hahn-echo experiments, which detect conformational exchange on the µs-ms timescale.
Pinpointing the collagen I interaction interface on β 2 m through 15 N-DEST.
In order to determine which residues of β 2 m interact most intimately with collagen I, we used 15 N-DEST experiments 56-57 . This experiment is optimal when there is a measurable increase in R 2 due to formation of a transient, large complex that is NMR-invisible because of its high R 2 and detects the exchange between an observable 'light' state (free monomeric β 2 m) and the NMR-invisible 'dark' state (the high molecular weight collagen I-β 2 m complex). In the DEST experiment, high molecular weight species with high R 2 values, such as the collagen I-β 2 m complex, can be partially saturated by weak radiofrequency (RF) fields at frequency offsets where monomeric β 2 m is not saturated. Saturation transfer to the observable monomeric species by chemical exchange is detected as a loss in monomeric β 2 m signal intensity. The broadening of these DEST saturation profiles (reduced signal intensities at further frequency offsets) in the presence of collagen I, relative to in its absence, is therefore indicative of residues at the interaction interface ( Figure 3A-B ). The 'broadness' of the profiles was measured by calculating the DEST difference (Θ) for each residue, which is a measure of the relative effects of on-resonance and off-resonance 15 N saturation. Using a saturation frequency of 350 Hz, we measured Θ as: =
were the most off-resonance 15 N offsets, and 15 N offsets of ±4 kHz provide enough saturation transfer from bound to unbound β 2 m to show significant intensity loss without eliminating the signal in most cases. A substantial change in Θ (ΔΘ) upon addition of collagen I is reflective of residues at the binding interface ( Figure 3A) . Notably, we observe that the broadening of the DEST saturation profiles is residue-specific and not uniform across all β 2 m residues, with some residues showing no change in the DEST difference in the presence of collagen I ( Figure  3A-B ). Examples of DEST profiles in the presence or absence of collagen I for a residue that shows DEST due to collagen I binding (V82 in β-strand F) and one that does not (K41 in the C-C' loop) are given in Figure 3B . In Figure 3A , those residues with ΔΘ larger than the mean, and likely have the most direct contacts with the collagen in the β 2 m-collagen I complex (shaded red), include residues 6-11 (β-strand A), [15] [16] [17] [18] [19] [20] In addition, the full DEST profiles can be used to quantify residue-specific transverse relaxation values of β 2 m in the collagen I-bound state (R 2 bound ) and exchange kinetics between the bound and unbound β 2 m. Since the ΔR 2 may be due to more complex processes than collagen I binding alone, such as an overall increased viscosity due to the presence of the large collagen I molecules, we fit only the 15 N DEST profiles of each residue with 150 Hz and 350 Hz RF saturation to the McConnell equations 56-57 . Fitting to a simple two-state model, the population of the unbound, monomeric β 2 m was determined to be 94 +/-2% with an apparent first-order rate constant for the conversion of β 2 m from unbound to collagen I-bound conformation (k on app ) of 6.4 +/-0.8 s -1 . We interpret the direct binding interface to be the residues with the highest R 2 bound . The 15 N-R 2 bound profile shows a similar trend to the ΔΘ profile ( Figure 3A, C) , and suggests that binding interfaces for collagen I on β 2 m occur on both β-sheets. Examples of fitting to the experimental values of residues V82 (in a binding region) and K41 (away from interface) are shown in Figure 3D . Collagen I induced conformational exchange in β 2 m revealed by 15 N relaxation.
The enhanced 15 N-R 2 of β 2 m may not only be due to binding with a high molecular weight species (such as in a large complex), but also to an increase in conformational exchange dynamics of β 2 m on the µs-ms timescale, since the 15 N-ΔR 2 is dependent on the magnetic field ( Figure S2 ). In order to determine which residues in β 2 m are in conformational exchange in the presence of collagen I, we use 15 Figure 4A ). The N-terminus and residues in the BC and DE loops (for which several signals are unobservable) are natively in conformational exchange ( Figure 4A ). Upon addition of 0.6 mg/ml collagen I, the regions with high R ex are expanded to include the full N-terminal β-strand A, part of β-strand B to part of β-strand C, including the connecting BC loop, β-strand D, the DE loop, the C-terminal end of β-strand F into the FG loop, and the C-terminal β-strand G ( Figure 4B ). Conformational dynamics in specific regions of β 2 m, including the N-terminal region and the BC loop that contains cis Pro32, have been shown to be crucial in controlling the amyloidogenicity of the protein 49, 58 . Thus, the enhanced conformational exchange induced by the presence of collagen I may facilitate minor populations of amyloid-component states of β 2 m.
DISCUSSION
A novel collagen I binding surface on β 2 m.
Amyloid formation of β 2 m at physiological pH in vitro requires assistance by co-factors 21, 25-26, 28-29, 31-49 . In particular, ECM molecules, such as collagens and GAGs have been targeted as amyloid-inducing co-factors, since β 2 m amyloid formation has been localized to musculoskeletal tissues 16, [22] [23] [24] . While previous experiments have focused on the kinetics of amyloid formation in the presence of these molecules 21, 28-29, 31, 59 , a detailed atomistic description of the interactions involved and how these may enhance β 2 m conformational dynamics and amyloid formation had not been elucidated. Here, we have used complementary NMR relaxation-based experiments to pinpoint residues of β 2 m involved in the collagen I binding interface and collagen I-induced dynamics that lead to enhanced β 2 m amyloid formation at neutral pH in vitro. The 15 N-DEST experiments indicate that residues in β-strands A, B, C, D, E, F, and G form interaction surfaces with collagen I. These provide two surfaces of mixed hydrophilic and hydrophobic composition (Fig. S3 ). Both contain hydrophobic patches with the ABED β-sheet displaying several aromatic residues on the interaction surface ( Fig. S3 ). Since both β-sheets on opposite sides of the molecule were determined to interact with the collagen I surface, binding must be multimodal involving interaction surfaces formed by K6, Q8, Y10, F22, N24, Y26, S52, Y63, L65, Y67, and E69 on the ABED β-sheet and E36, D38, L40, A79, R81, N83, I92, and K94 on the GFC β-sheet ( Figure  3, S3 ). Comparison of the molecular dimensions of the interacting molecules (4 x 2 x 2 nm for β 2 m, 300 nm x 1.5 nm for a collagen I triple helix, and microns in length x up to 500 nm in diameter for mature collagen I fibrils) highlights the potential for a myriad of binding modes, enabling independent binding of several β 2 m molecules to the same collagen molecule ( Figure 5A-B) . Importantly, the collagen I triple helix surface is interspersed with numerous hydrophilic and hydrophobic residues along its length ( Figure 5A ). The collagen I fibril surface maintains this repeating pattern of surface chemistries ( Figure 5B ), enhancing the potential for multiple binding modes to complementary surfaces in β 2 m ( Figure 5C ). Collagen I is known to interact with multiple immunoglobulin-like protein folds through binding interfaces that include both hydrophobic and hydrophilic residues. Interactions of collagen I with osteoclast-associated receptor (OSCAR), leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), and glycoprotein VI (GPVI), play functional roles in immune system regulation 61-64 and platelet activation 65-67 . Similar to the β-sheet binding interface on β 2 m for collagen I identified here, the collagen I binding sites on OSCAR and LAIR-1 are also found in βsheet regions [68] [69] . In the case of the OSCAR-collagen I interactions, Tyr and Arg residues that line the interacting β-sheet of OSCAR have been suggested to play a primary role 68 . LAIR-1 binds primarily to collagen fragments rich in Gly, Pro and hydroxyproline (GPO) content, but also has been shown to interact with multiple binding motifs in collagen II and III toolkit peptides, some of which are not GPO rich 69 . NMR and mutagenesis studies on LAIR-1 have shown that depletion of Arg or Glu at the putative β-sheet interface showed decreased collagen binding, suggesting a role for electrostatic interactions 70 . GPVI, also recognizes GPO rich collagen motifs, however through a unique hydrophobic groove formed by a β-strand connecting loop that is flanked by hydrophilic residues 71-73 . Thus, although these proteins all share a similar immunoglobulin fold, each shows a unique binding interface to collagen, interacting in grooves formed by β-sheets or loops and having both hydrophobic and hydrophilic residues that each play fundamental roles in binding.
Collagen-induced conformational dynamics in β 2 m reflect amyloid prone dynamics.
Beyond the structured collagen I-binding interface of β 2 m, using 15 N relaxation experiments, we observe enhanced dynamics in the N-and C-termini, BC and FG loops, and the β-strand D of β 2 m upon complex formation. Enhanced dynamics in each of these regions has been proposed to play key roles in the aggregation mechanism of wild-type β 2 m 38, 49-51, 74-84 . Amyloid formation of β 2 m is nucleation dependent and proceeds through a near native folding intermediate, I T , that is in part defined by a non-native trans-His31-Pro32 peptide bond in the BC loop 38, 50-51, [85] [86] . The cis-trans isomerization of Pro32 is aided by displacement of the N-terminal six residues, which destabilizes the BC loop, allowing β 2 m to sample multiple amyloidogenic conformations that enhance the rate of aggregation 38, 50-51, 74, 79-81, [85] [86] . Deletion of the first six N-terminal residues in the naturally occurring variant, ΔN6, enhances the propensity for amyloid formation, and aggregation occurs in the absence of additional cofactors at physiological pH in vitro 49, 74, [87] [88] . In addition, NMR relaxation experiments show enhanced dynamics in βstrand D and the DE loop of amyloidogenic ΔN6 49 , which have been proposed to contribute to its higher aggregation propensity. NMR studies of a P32G-β 2 m variant, which inherently has a trans-His31-Gly32 peptide bond, showed significant line broadening in β-strands A and D and the BC and FG loops relative to WT-β 2 m 38 . This was interpreted to result from conformational conversion between the native and I T conformations 38 . The observation of increased R ex of these same regions upon addition of collagen I to WT-β 2 m, in this study, is consistent with the same regions undergoing conformational exchange from the native state to an amyloidogenic precursor consistent with the I T state, to enhance amyloid formation. Such a model provides a mechanism to enhance cis-trans Pro isomerization to initiate assembly into amyloid without the involvement of a prolyl isomerase. A proposed mechanism of collagen I-driven β 2 m amyloidogenesis.
With the new insights into the binding interface of collagen I on β 2 m and its impact on β 2 m dynamics described here, we propose a mechanistic view of how collagen I drives amyloidogenesis of β 2 m. In the presence of collagen I, the β-sheets of β 2 m are available for binding to the collagen I surface, with both β-sheets providing potential binding interfaces, indicative of multiple binding modes, rather that a unique and specific binding interface. The interaction between the two molecules is mediated by hydrophobic and electrostatic interactions (Figures 3, S3 ). In its native state, high transverse relaxation rates are observed in the apical loops of β 2 m, including the BC loop that contains cis Pro32 and the adjacent DE loop ( Figure 2B ). Additional dynamics upon collagen I binding are imposed on the N-terminus, β-strands B and C, BC loop, β-strand D, FG loop, and the C-terminal β-strand G ( Figure 4B ). Through modification of the dynamics of β 2 m in these sites, the probability of cis-trans isomerization of Pro32, known to be a key step in β 2 m fibril formation [85] [86] , will be increased, with concomitant sampling of amyloid-competent species, including the I T state, known to promote amyloid formation 38, 50-51 ( Figure 6 ). The results provide a molecular explanation for the mechanism of deposition of β 2 m in collagenous-rich joints in dialysis patients 16, [21] [22] [23] [24] . More generally, they also serve as an exemplar of the key role of the physiological environment in amyloid formation, by rationalizing the often remarkably specific deposition of amyloid to different tissues 1 , and in some cases, of different variants of the same protein in different tissues [89] [90] . The methods used here to interrogate the weak-transient interaction of the large, β 2 m-collagen I complex can be extended to future studies to gain atomiclevel insight into how other physiologically relevant cofactors promote amyloid formation of globular proteins involved in other amyloid diseases.
MATERIALS AND METHODS Expression and purification of β 2 m.
Wild-type β 2 m was expressed recombinantly in Escherichia coli BL21(DE3) pLysS cells by induction with 1 mM IPTG overnight at 37°C, following methods described previously 39 
ELISA.
Relative adhesion of variable concentrations of β 2 m to collagen I was determined by ELISA experiments. Nunc Maxisorp 96-well plates (Thermo Scientific) were coated with 100 µl of collagen I from rat tail tendon (BD Biosciences; 10 µg/ml in 10 mM acetic acid) overnight at 4°C. Uncoated areas on the plates were blocked with 200 µl of 0.5% w/v casein in binding buffer at room temperature for 1 hr. The binding and washing buffer consisted of PBS at pH 7.4 with 0.05% v/v Tween 20 (PBS-T) and 0.05% w/v casein as a non-specific blocking agent. After washing the wells three times with 200 µl washing buffer, 100 µl β 2 m in PBS-T and 0.05% w/v casein (10 µg/ml, 40 µg/ml, or 80 µg/ml) was added to the wells and incubated for 1 hr at room temperature. After three washes with 200 µl washing buffer, 100 µl mouse antiβ 2 m monoclonal antibody (1:2000 v/v in PBS-T and 0.05% w/v casein, Millipore Sigma) was bound to β 2 m in each well by incubating at room temperature for 1 hr. Subsequently, following three washes with 200 µl washing buffer, 100 µl of goat HRP-conjugated anti-mouse secondary antibody (1:5000 v/v dilution in PBS-T and 0.05% w/v casein, Genscript) was incubated in the wells at room temperature for 30 min. After washing for a final four times with 200 µl washing buffer, the binding of β 2 m to collagen I was detected through a colorimetric assay using a 3,3',5,5'-tetramethylbenzidine substrate kit (Pierce) according to the manufacturer's protocol, and measuring the absorbance at 450 nm using a Tecan Infinite F50 plate reader with Magellan software. ThT fluorescence.
Amyloid fibril formation was monitored by ThT fluorescence assays of β 2 m in the presence or absence of collagen I fibrils. Purified recombinant β 2 m lyophilized powder was dissolved in 100 µl of 10 mM sodium phosphate buffer, pH 7.4 to 1 mg/ml (85 µM). Collagen I fibrils were prepared by incubating 3.4 mg/ml collagen I (BD Biosciences) in PBS, pH 7.4 at 37°C for 1 hr. The fibril suspension was sonicated in a bath sonicator for 10 min and centrifuged at 16,500 rpm for 10 min to isolate fibrils. Collagen fibril pellets were resuspended in 100 µl of 10 mM sodium phosphate buffer, pH 7.4 in the presence or absence of β 2 m. Three or four samples were prepared for each condition and were transferred to a 96-well plate. ThT was added to each sample to a final concentration of 10 µM. ThT fluorescence was monitored over 22 days at 37°C with shaking at 600 rpm in a POLARstar Omega fluorimeter (BMG Labtech).
NMR.
For all NMR experiments, purified recombinant [U-15 N]-labeled β 2 m was diluted to 300 µM in TBS, pH 7.4 with 0.5 mg/ml casein and 10% v/v D 2 O. Before mixing, collagen I from rat tail tendon was dialyzed against TBS, pH 7.4. The concentration of collagen I after dialysis was determined by bicinchoninic acid assay (Pierce). All experiments were performed at 10°C. All data were collected on a 700 MHz Bruker AVIII or 900 MHz AVI NMR spectrometers equipped with TCI-cryo-probes. Data were processed in NMRPipe 91 and analyzed in Sparky 92 . 1 H-15 N HSQC spectra 1 H-15 N HSQC spectra [93] [94] of [U-15 N]-labeled β 2 m were acquired with different concentrations of collagen I (0, 0.12 mg/ml, and 1.2 mg/ml) in TBS, pH 7.4 with 0.5 mg/ml casein and 10% D 2 O at 10°C. The intensity ratio is taken as the intensity of a given cross-peak in the 1 H-15 N HSQC spectrum of β 2 m in the presence of collagen I relative to the intensity of the same cross-peak in the absence of collagen I, determined in Sparky 92 . The errors were propagated from the signal to noise ratio in each spectra. 15 
DEST experiments
The 15 N-DEST experiment 56-57 was applied to [U-15 N]-labeled β 2 m in the presence or absence of 0.6 mg/ml collagen I. In this experiment, an 15 N saturation pulse of 150 or 350 Hz was applied for 0.9 ms at different 15 N frequency offsets: 0, ±1, ±2, ±4, ±8, ±14, ±21, and ±30 kHz. An experiment in which the 15 N saturation pulse was set to 0 Hz with an offset of 30 kHz was also included as a reference. The 15 N-DEST profiles were extracted for each residue as the peak intensity at each 15 N saturation offset and were fitted to a two-state model using the destfit program by Clore and co-workers to obtain R 2 bound , p bound , and k on app56-57 . The ΔΘ profile was obtained by measuring Θ for each β 2 m residue in the presence and absence of 0.6 mg/ml collagen I as: = ! !"!"# !! !!"!"# !(! !!"# !! !!!"# ) ! !"!"# !! !!"!"# , and taking ΔΘ = Θ +col -Θ -col .
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